These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. For organ transplant recipients, cancer threatens long-term survival. Ross K J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827 [No Abstract] [Full Text] [Related]
3. Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature. Framarino-dei-Malatesta M; Derme M; Manzia TM; Iaria G; De Luca L; Fazzolari L; Napoli A; Berloco P; Patel T; Orlando G; Tisone G Expert Rev Clin Immunol; 2013 Aug; 9(8):781-9. PubMed ID: 23971756 [TBL] [Abstract][Full Text] [Related]
4. Sirolimus: a new immunosuppressant. Mukherjee T; Shah BV J Assoc Physicians India; 2005 Oct; 53():885-90. PubMed ID: 16459533 [TBL] [Abstract][Full Text] [Related]
5. Sirolimus does not reduce receptor-mediated endocytosis of albumin in proximal tubule cells. Mreich E; Coombes JD; Rangan GK Transplantation; 2007 Jan; 83(1):105-7. PubMed ID: 17220808 [No Abstract] [Full Text] [Related]
8. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation]. Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812 [TBL] [Abstract][Full Text] [Related]
9. Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors. Cruzado JM Transplant Rev (Orlando); 2008 Jan; 22(1):73-81. PubMed ID: 18631860 [TBL] [Abstract][Full Text] [Related]
10. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials. Demopoulos L; Polinsky M; Steele G; Mines D; Blum M; Caulfield M; Adamkovic A; Liu Q; Harler MB; Hahn C; Singh A Transplant Proc; 2008 Jun; 40(5):1407-10. PubMed ID: 18589118 [TBL] [Abstract][Full Text] [Related]
11. [Complications of immunosuppressive therapy in organ transplantation]. Jørgensen KA; Dieperink H; Kirkegaard P Ugeskr Laeger; 2003 Dec; 165(49):4727-9. PubMed ID: 14708378 [No Abstract] [Full Text] [Related]
12. [Pro- and antitumor effects of the main immunosuppressive drugs used in the clinical practice of transplantation]. Marchini F G Ital Nefrol; 2007; 24(2):171. PubMed ID: 17458835 [No Abstract] [Full Text] [Related]
13. Pharmacogenetics in solid organ transplantation: current status and future directions. de Jonge H; Kuypers DR Transplant Rev (Orlando); 2008 Jan; 22(1):6-20. PubMed ID: 18631854 [TBL] [Abstract][Full Text] [Related]
14. Immunosuppression in pediatric solid organ transplantation: opportunities, risks, and management. Tredger JM; Brown NW; Dhawan A Pediatr Transplant; 2006 Dec; 10(8):879-92. PubMed ID: 17096754 [TBL] [Abstract][Full Text] [Related]